Hints and tips:
...One thing to start: Tiffany’s board has agreed to a slightly lower price to greenlight the sale of the US jeweller to LVMH, ending a bitter conflict triggered by the Covid-19 pandemic that threatened to...
...One of the latest deals Buffett declined to entertain was a multibillion-dollar buyout of famed jeweller Tiffany & Co, which contacted the so-called Oracle of Omaha after it had received a takeover offer...
...The bank nonetheless enjoyed a blockbuster payday for its work advising Bristol-Myers Squibb on its takeover of Celgene, a deal that generated Morgan Stanley an $82m advisory fee JPMorgan Chase reported...
...France’s LVMH agreed to buy US jeweller group Tiffany & Co for nearly $17bn and Swiss drugmaker Novartis acquired the Medicines Company for $9.7bn....
...Jeffery Norton has rejoined O'Melveny & Myers in the corporate finance practice in New York from Dechert where he was a partner....
...LVMH then did some shopping for itself — popping over to New York to buy Tiffany in a $16.6bn deal. Thank you for reading this year....
...Separately, Jana’s activist approach also took effect at US drugmaker Bristol-Myers Squibb, which said on Tuesday that it had appointed three new directors to its board and unveiled a $2bn share buyback...
...The move is the second board shake-up involving Jana Partners today after luxury jeweller Tiffany said it was appointing three new directors to its board in a deal with the activist investor....
...Earlier this year the hedge fund negotiated behind the scenes to achieve boardroom shake-ups at Tiffany and Bristol-Myers Squibb and has also invested in Walgreens Boots Alliance and Safeway ahead of its...
...Earlier this year, the fund negotiated behind the scenes to achieve boardroom shake-ups at Tiffany and Bristol-Myers Squibb....
...Bristol-Myers Squibb gave up 2.9 per cent to $22.12, while Merck lost 1.7 per cent to $32.32....
...Tiffany's lost 12.1 per cent on the week while Gap lost 13.4 per cent. Other corporate news this week included settlements with regulators by Halliburton and Bristol Myers-Squibb....
International Edition